Dr Arias has many years of experience in the assessment of drug products. He has provided expert advice for a number of drug safety regulatory initiatives and represented Health Canada in various international drug regulatory technical committees (e.g., ICH, PAHO). He is an adjunct professor at the Fac. Pharmacy of the Université de Montréal, an active member of the Signal Panel of the the Uppsala Monitoring Centre, and a former North America Government/Regulatory ISPE Board representative.